NASDAQ:EARS Auris Medical (EARS) Stock Price, News & Analysis → the most reliable asset on earth is making a comeback (From DTI) (Ad) Free EARS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$2.22▼$2.4050-Day Range$2.25▼$3.2752-Week Range$0.73▼$6.60Volume328,573 shsAverage Volume3.10 million shsMarket Capitalization$26.83 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsHeadlinesSocial MediaStock AnalysisCompetitorsHeadlinesSocial Media Get Auris Medical alerts: Email Address Ad Crypto 101 MediaCrypto Market Preps For Trillions Worth of Inflows! Bitcoin is rapidly approaching new ALL-TIME HIGHS… The market is buzzing after recent approval of spot Bitcoin exchange-traded funds (ETF). Top analysts predict these ETFs will attract trillions of dollars worth of inflows over the next few years… And as Bitcoin rallies, we could see other smaller coins rise to heights never seen before.Click to join the Crypto Community Summit Free Online Event About Auris Medical Stock (NASDAQ:EARS)Auris Medical Holding Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through Switzerland and Australia geographical segments. Its product pipeline includes AM-125, AM-201, AM301, Sonsuvi, and Keyzilen. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda.Read More Ad Crypto 101 MediaMajor Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. EARS Stock News HeadlinesMarch 13, 2024 | msn.comRevolutionary Smartphone App Diagnoses Ear Infections in ChildrenMarch 10, 2024 | yahoo.comWhy Pimples Form in the Ear—And How to Get Rid of ThemMarch 28, 2024 | Crypto 101 Media (Ad)Altcoin FRENZY Alert…Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days… March 7, 2024 | markets.businessinsider.comEssential Guide for Alleviating Itchy Ears, with Expert Insights from Dr. Emily McMahanFebruary 28, 2024 | msn.comCandida Auris Fungus Infection: Symptoms, Spread, TreatmentFebruary 24, 2024 | msn.comEar-Tok: Doctors warn of the risks of TikTok ear-cleaning trendFebruary 18, 2024 | msn.comAre Your Ears Ringing? 10 Ways to Manage TinnitusFebruary 15, 2024 | msn.comEar doctor reveals the weirdest things he's ever yanked outMarch 28, 2024 | DTI (Ad)Warning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…February 14, 2024 | msn.comNew ear tube procedure for children can be done in five minutesFebruary 11, 2024 | msn.com'No common symptoms' for deadly fungal disease sweeping US poses 'challenges' for expertsFebruary 8, 2024 | msn.comMap shows spread of deadly fungal disease across US killing one in three patientsFebruary 8, 2024 | msn.comThe deadly fungal disease C. auris spreading across the US explained - symptoms, treatment and outbreaksFebruary 6, 2024 | msn.comWhat to know about Seattle's potentially deadly fungus outbreakFebruary 6, 2024 | msn.comDeadly 'Candida auris' fungal infection spreading rapidly across US with 60% death rateFebruary 6, 2024 | nytimes.comWhat’s the Best Way to Clean Your Ears?February 6, 2024 | msn.comCandida Auris Outbreak: Know About This Fatal Fungal Infection Spreading Like Wildfire in the USAFebruary 5, 2024 | msn.comDeadly Fungal Infection Spreading to New Parts of U.S., CDC WarnsFebruary 5, 2024 | msn.com'Nightmare' deadly fungal infection with 60% fatality rate spreading rapidly across USFebruary 5, 2024 | msn.comRare virus detected in US: 4 ‘Candida Auris’ cases reported in Washington – Know all about its symptoms, prevention and historyFebruary 5, 2024 | mirror.co.ukDeadly fungal infection 'Candida auris' with death rate of 60% spreading rapidlyFebruary 4, 2024 | msn.comCandida auris: Symptoms to prevention, all about the deadly fungal infection spreading in USFebruary 4, 2024 | msn.comDeadly fungus, Candida Auris, emerges in US: All you need to knowFebruary 3, 2024 | ca.style.yahoo.comAngela Rippon gives health update after she ‘stopped breathing’ on Strictly tourFebruary 3, 2024 | msn.comWashington state sees outbreak of deadly Candida auris infection; know symptoms and ways to prevent itFebruary 2, 2024 | msn.comWhy the Deadly Fungus Candida Auris Is Scaring PeopleFebruary 1, 2024 | msn.comSeattle Reports Outbreak Of Rare, Drug-Resistant Fungal Infection: Here’s What To KnowSee More Headlines Receive EARS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Auris Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/11/2017Today3/28/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:EARS CUSIPN/A CIK1601936 Webwww.aurismedical.com Phone(441) 295-5950FaxN/AEmployees132,200Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio3.83 Quick Ratio3.83 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.57 per share Price / Book1.50Miscellaneous Outstanding Shares11,417,000Free FloatN/AMarket Cap$26.83 million OptionableNot Optionable Beta1.17 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesThomas MeyerChairman & Chief Executive OfficerElmar SchärliChief Financial OfficerSamuel A. WicklineChief Scientific OfficerAndrea VondraskovaMedical DirectorKey CompetitorsFSD PharmaNASDAQ:HUGESol-Gel TechnologiesNASDAQ:SLGLOrgenesisNASDAQ:ORGSLipocineNASDAQ:LPCNSpruce BiosciencesNASDAQ:SPRBView All Competitors EARS Stock Analysis - Frequently Asked Questions How were Auris Medical's earnings last quarter? Auris Medical Holding Ltd. (NASDAQ:EARS) issued its earnings results on Thursday, May, 11th. The biotechnology company reported ($4.40) EPS for the quarter, missing analysts' consensus estimates of ($2.80) by $1.60. When did Auris Medical's stock split? Auris Medical shares reverse split on Wednesday, May 1st 2019. The 1-20 reverse split was announced on Tuesday, April 30th 2019. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, April 30th 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What other stocks do shareholders of Auris Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Auris Medical investors own include Helios and Matheson Analytics (HMNY), Anavex Life Sciences (AVXL), OPKO Health (OPK), Rigel Pharmaceuticals (RIGL), Flexion Therapeutics (FLXN), Novavax (NVAX), Iconix Brand Group (ICON), Onconova Therapeutics (ONTX) and Nabriva Therapeutics (NBRV). This page (NASDAQ:EARS) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research Advisory Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Auris Medical Holding Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.